Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT02274233
Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2014
Completion: Sep 30, 2015